We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.4B
AUM Growth
+$3.53B
(+32%)
Cap. Flow
+$2.81B
Cap. Flow
% of AUM
19.5%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
1,820
New
468
Increased
1,221
Reduced
109
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$116M |
| 3 |
Amazon
AMZN
|
+$84.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$57.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.3M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$6.62M |
| 3 |
VF Corp
VFC
|
+$4.38M |
| 4 |
W.W. Grainger
GWW
|
+$3.97M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.64% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 13.98% |
| 4 | Consumer Staples | 10.45% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Capitol Federal Financial
CFFN
$1.08B
| $528K | ﹤0.01% |
39,375
+11,401
| +41% | +$160K |
|
1102
CytomX Therapeutics
CTMX
$705M
| $528K | ﹤0.01% |
+25,006
| New | +$518K |
|
1103
WEX
WEX
$6.11B
| $527K | ﹤0.01% |
3,733
+1,021
| +38% | +$128K |
|
1104
BGC Group
BGC
$5.58B
| $526K | ﹤0.01% |
54,089
+3,671
| +7% | +$37.1K |
|
|
HI
1105
DELISTED
Hillenbrand
HI
| $526K | ﹤0.01% |
11,774
+5,922
| +101% | +$248K |
|
1106
Live Nation Entertainment
LYV
$41.2B
| $526K | ﹤0.01% |
12,351
+3,024
| +32% | +$132K |
|
1107
Nexstar Media Group
NXST
$5.6B
| $526K | ﹤0.01% |
6,726
+3,392
| +102% | +$228K |
|
|
ALDR
1108
DELISTED
Alder Biopharmaceuticals
ALDR
| $526K | ﹤0.01% |
45,916
+3,419
| +8% | +$38.2K |
|
1109
LiveRamp
RAMP
$2.29B
| $523K | ﹤0.01% |
18,979
+8,091
| +74% | +$212K |
|
1110
Rogers Corp
ROG
$2.33B
| $523K | ﹤0.01% |
3,233
+1,638
| +103% | +$247K |
|
1111
Boyd Gaming
BYD
$6.47B
| $520K | ﹤0.01% |
+14,835
| New | +$449K |
|
1112
Moog Inc Class A
MOG.A
$13B
| $520K | ﹤0.01% |
5,982
+2,983
| +99% | +$256K |
|
1113
CRISPR Therapeutics
CRSP
$4.58B
| $519K | ﹤0.01% |
+22,100
| New | +$420K |
|
1114
Zebra Technologies
ZBRA
$12.4B
| $517K | ﹤0.01% |
4,976
+1,366
| +38% | +$149K |
|
|
ITCI
1115
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $517K | ﹤0.01% |
35,705
+8,929
| +33% | +$138K |
|
1116
Eagle Materials
EXP
$6.6B
| $515K | ﹤0.01% |
4,549
+1,252
| +38% | +$135K |
|
1117
Carter's
CRI
$1.43B
| $514K | ﹤0.01% |
4,379
+1,166
| +36% | +$121K |
|
|
ATNX
1118
DELISTED
Athenex, Inc. Common Stock
ATNX
| $514K | ﹤0.01% |
+1,615
| New | +$553K |
|
|
GCP
1119
DELISTED
GCP Applied Technologies Inc.
GCP
| $514K | ﹤0.01% |
16,109
+6,951
| +76% | +$214K |
|
1120
Yelp
YELP
$1.38B
| $513K | ﹤0.01% |
12,223
+6,537
| +115% | +$291K |
|
1121
TripAdvisor
TRIP
$1.59B
| $512K | ﹤0.01% |
14,855
+4,741
| +47% | +$171K |
|
|
UFS
1122
DELISTED
DOMTAR CORPORATION (New)
UFS
| $512K | ﹤0.01% |
10,334
+2,479
| +32% | +$115K |
|
1123
MasTec
MTZ
$26.7B
| $511K | ﹤0.01% |
10,447
+5,498
| +111% | +$245K |
|
|
VRNT
1124
DELISTED
Verint Systems
VRNT
| $507K | ﹤0.01% |
23,794
+11,231
| +89% | +$242K |
|
|
EGRX
1125
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $507K | ﹤0.01% |
9,486
+211
| +2% | +$11.7K |
|
Similar funds
ProShare Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ProShare Advisors held 1,820 positions worth $14.4B, up 32% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors deployed $2.81B of net new capital in Q4 2017, opening 468 new positions and adding to 1,221 existing holdings. Its largest new stake was ASML: 31,220 shares worth $5.43M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VF Corp, an estimated $4.38M trimmed.
- ProShare Advisors's largest Q4 2017 buy was ASML: 31,220 shares worth $5.43M.
- ProShare Advisors added most to Apple in Q4 2017, an estimated $160M increase.
- ProShare Advisors's biggest Q4 2017 reduction was VF Corp, cutting an estimated $4.38M.
- ProShare Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.3M.
- ProShare Advisors's ten largest holdings make up 18% of its $14.4B portfolio in Q4 2017.
- ProShare Advisors opened 468 new positions and closed 21 in Q4 2017.
- ProShare Advisors's portfolio value rose 32% quarter-over-quarter to $14.4B.
Based on ProShare Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.